semaglutide for alcohol rebound The Department of Veterans Affairs on Thursday announced a clinical trial to test whether injectable semaglutide, a GLP-1 drug widely prescribed diabetes and weight loss can also treat abuse, a Popular GLP-1 drugs such as

10.1038/nn.4540 69 TurtonM

How the Procedure Works Some medications are preloaded with a pre-determined dosage and can be injected or taken orally by the patient independently qr

E.DaytonM.GibbsJ

Dr Hungerford says we need more long-term, large-scale studies to see how these medications impact people living with eating disordersincluding what happens when they stop using them as weight gain can be triggering for someone experiencing, or at risk of developing, an eating disorder

Aromatase inhibitor joint pain Joint pain is the most common reason women stop aromatase inhibitor therapy early, and stopping AI treatment ahead of schedule is associated with higher recurrence risk

A separate meta-analysis of randomized trials and observational studies found lower alcohol-related events among GLP-1 users, including among patients with alcohol use disorder